A brain bleed from a ruptured aneurysm is a terrifying event that leaves patients and families facing a long road to recovery. A new look at data from four major hospitals in China offers a potential clue about how to help patients survive the first month. Researchers found that people who took statins before their admission had a much higher chance of a favorable outcome at 30 days. This favorable outcome means the patient recovered well enough to perform daily tasks without major disability. The odds of this good result were 3.67 times higher for those on statins compared to those who were not. This association held true even after carefully matching the two groups to ensure a fair comparison. It is important to remember that this was an observational study, meaning researchers watched what happened naturally without assigning the drug. Because of this design, we cannot say the statins caused the better recovery. Other factors like baseline cholesterol levels and alcohol use also played a role in the results. The study did not report any safety concerns or side effects for the patients taking the medication during this short window. However, the good news did not last. When the team looked at recovery at 90 days, the benefit of statins disappeared. The initial boost in recovery did not extend to the longer term. Experts say we need more rigorous trials to confirm these findings before changing how doctors treat patients.
Pre-admission statin use linked to better 30-day outcomes after aneurysmal SAHPre-admission statin use linked to better 30-day outcomes in brain bleed patients
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Interpret pre-admission statin use in aSAH as associated with better 30-day outcomes, but causality is unproven and benefit wanes by 90 days.
This real-world observational study examined the association between pre-admission statin use and outcomes in patients with aneurysmal subarachnoid hemorrhage (aSAH). Data were collected from four Chinese tertiary medical centers, including 1,431 patients, of whom 821 met inclusion criteria (367 statin users, 454 non-users). After propensity score matching, each group had 220 patients.
The primary outcome was favorable outcome at 30 days, defined as modified Rankin Scale score 0-2. Pre-admission statin use was associated with a higher likelihood of favorable outcome (OR 3.67, 95% CI 2.46-5.47). However, this benefit did not extend to 90-day prognosis.
Safety and tolerability data were not reported. Limitations include the observational design, which precludes causality, and effect variation according to baseline LDL-C levels and alcohol consumption. The study population was from Chinese centers, limiting generalizability.
Clinicians should interpret these results cautiously. The association requires confirmation by multicenter, international randomized controlled trials before any practice changes.
What this means for you:
Early statin use linked to better 30-day recovery after brain bleed, but benefits faded by 90 days. More on Aneurysmal Subarachnoid Hemorrhage
Multi-target therapies may address combined hypertension and dyslipidemia pathophysiology
Multi-Target Therapies May Address Combined Hypertension and High Cholesterol
This systematic review synthesizes evidence on synergistic mechanisms of hypertension and dyslipidemia, highlighting the RAAS/PPAR axis, AMP…
Combining treatments like statins and RAAS inhibitors may offer a more precise way to manage both high blood pressure and cholesterol levels…
Research in coronary heart disease shows misalignment between investment and clinical guideline priorities
China's heart disease research focuses on bioequivalence, not innovation
This guideline-based research trend analysis of 3,339 publications identifies a significant gap between current research investments and cli…
A review of 3,339 publications shows China's coronary heart disease research heavily emphasizes bioequivalence studies over innovative drug …
Microcirculatory dysfunction during cardiac surgery remains heterogeneous and inconclusive in current clinical evidence
Microcirculation in Cardiac Surgery: What We Know and What Remains Unclear
This narrative review examines microcirculatory dysfunction in patients undergoing cardiac surgery with cardiopulmonary bypass. The authors …
A review of cardiac surgery research shows mixed results on microcirculation, with many gaps between lab findings and patient care.
Evolocumab reduces cardiovascular events in diabetes without known atherosclerosis
Evolocumab cuts heart events in high-risk diabetes patients
This prespecified subgroup analysis of a phase 3 RCT evaluated evolocumab added to statin therapy in 3655 high-risk patients with type 2 dia…
Adding evolocumab to statins reduced heart attacks and strokes by about 30% in high-risk diabetes patients without known heart disease.
View Original Abstract ↓
Subarachnoid hemorrhage (SAH) from ruptured intracranial aneurysms is a severe stroke subtype with a high mortality rate. Statins, noted for cholesterol-independent benefits, are being studied as potential treatments, but their effectiveness is debated. This study assesses the impact of pre-admission statin therapy on aneurysmal SAH outcomes.
This was a multicenter, observational, real-world study from May 2012 to May 2023 at four Chinese tertiary medical centers. Patients were divided into statin and control groups based on pre-admission statin use. The primary outcome was favorable outcome at 30 days, defined as a modified Rankin Scale (mRS) score of 0–2. Propensity score matching (PSM) was applied to balance baseline characteristics. The trial was registered with Chinese Clinical Trial Registry (ChiCTR2300079305).
Out of 1,431 patients, 821 met the inclusion criteria (statin group: 367; control group: 454). After PSM, each group comprised 220 patients. Pre-admission statin was associated with a higher likelihood of favorable outcome at 30 days (before PSM: odds ratio [OR] 3.67, 95% confidence interval [CI] 2.46–5.47, p
Pre-admission statin therapy was associated with improved prognosis at 30 days in patients with aneurysmal SAH, however this benefit could not extend to 90 days. The effect of statin appeared to vary according to baseline LDL-C levels and alcohol consumption. Further multicenter, international randomized controlled trials are warranted to confirm these findings.
Systematic review confirms clip anastomosis improves one and two year primary patency rates for arteriovenous fistula creation compared to suture methods
Vascular Clips Outperform Sutures for Dialysis Access Longevity
Related in Nephrology
Precision nutrition offers dynamic optimization for managing patients with chronic liver disease through individualized metabolic profiles
Precision nutrition offers a new way to manage liver disease
This narrative review explores the role of precision nutrition in managing chronic liver disease. The authors argue that tailoring nutrition…
Tailoring nutrition to an individual's unique metabolism could change how doctors manage chronic liver disease and improve patient care.
FDA Approves Terlivaz (terlipressin) for Hepatorenal Syndrome with Rapid Kidney Function Decline
FDA approves new drug Terlivaz for kidney failure in liver disease patients.
The FDA approved Terlivaz (terlipressin) to improve kidney function in adults with hepatorenal syndrome with rapid reduction in kidney funct…
The FDA approved Terlivaz (terlipressin) to improve kidney function in adults with hepatorenal syndrome, a serious kidney complication of ci…
Intraoperative anesthesia handovers are associated with increased risk of mortality and morbidity in surgical patients
Anesthesia handovers during surgery are linked to higher patient risks
This systematic review and meta-analysis of 14 studies found that intraoperative anesthesia handovers are significantly associated with high…
Research shows that passing anesthesia care between staff during surgery is linked to higher rates of complications and longer stays in inte…
Adolescent physical activity is associated with improved mental and physical health in early adulthood
Adolescent Physical Activity Linked to Better Health in Early Adulthood
This systematic review of 44 articles analyzed the impact of adolescent physical activity on health markers in early adulthood. The authors …
Staying active as a teenager may lead to better physical and mental health outcomes for young adults later in life.
From Other Specialties
Naive pooling of RCTs and non-randomized studies in network meta-analyses is common and problematic
Improving the Quality of Evidence Used in Medical Network Meta-Analyses
This protocol describes a meta-epidemiological study that will examine how often network meta-analyses naively pool randomized and non-rando…
Researchers plan to check if medical studies are mixing different types of evidence without proper adjustments, which could affect treatment…
Post-extubation dysphagia incidence ranges from 28.36% to 68.94% in critically ill children
High rates of swallowing problems found in children after intubation
This scoping review of 15 studies examines the incidence and predictors of pediatric post-extubation dysphagia (PED). The authors identify h…
Many critically ill children struggle to swallow safely after breathing tubes are removed, with some studies showing issues in up to 69% of …
Circular RNAs may regulate ferroptosis and anti-tumor immunity in cancer via multiple mechanisms
Circular RNAs may offer new ways to target cancer cells
This systematic review explores how circular RNAs (circRNAs) act as molecular bridges to simultaneously regulate ferroptosis and anti-tumor …
New research identifies circular RNAs as molecular bridges that could help doctors diagnose and treat cancer more precisely.
Meningeal Immune System Offers New Target for Glioblastoma Immunotherapy
New approach targets the immune system to treat brain tumors
This systematic review explores how targeting the meningeal immune system, including dural lymphatics and rBAMs, could overcome current barr…
A new strategy focuses on the area where brain tumors meet the body's defenses to improve how immunotherapy works for glioblastoma.